Mergers & Acquisitions - Otsuka


Current filters:


Popular Filters

Genesis 2013: Astex Pharma’s journey from biotech start-up to $886m success story

Genesis 2013: Astex Pharma’s journey from biotech start-up to $886m success story


A biotech company’s dream 14-year journey from small start-up to an $886 million takeover bid provided…

Asia-PacificAstex PharmaceuticalsBiotechnologyFinancialInterviewsMergers & AcquisitionsOtsukaUKUSA

Astex urges stockholders to tender shares into Otsuka offer


The board of directors of USA-based Astex Pharmaceuticalsissued a letter to stockholders addressing what…

Astex PharmaceuticalsMergers & AcquisitionsOtsukaPharmaceutical

Otsuka confirms takeover bid for Astex Pharmaceuticals for $886 million


Following heavy speculation on Wednesday (see The Pharma Letter story earlier today), this morning Japanese…

Astex PharmaceuticalsBiotechnologyMergers & AcquisitionsOncologyOtsukaPharmaceutical

Otsuka said to be buying Astex Pharma


Japanese mid-size drugmaker Otsuka (TYO: 4768) is planning to acquire USA-based Astex Pharmaceuticals…

Astex PharmaceuticalsBiotechnologyMergers & AcquisitionsOncologyOtsukaPharmaceutical

Claris Lifesciences dips on sale of infusions business


Indian drugmaker Claris Lifesciences (CLAI: BO) has dipped 4% to 264 rupees, declining over 6% from day's…

Asia-PacificClaris LifesciencesMergers & AcquisitionsMitsui & CoOtsukaPharmaceutical

Otsuka Pharma sets up joint venture in Turkey


Otsuka Pharmaceutical (TYO: 4768), a mid-size Japanese drugmaker, and Abdi ����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������°brahim…

Abdi IbrahimEuropeMarkets & MarketingMergers & AcquisitionsOtsukaPharmaceutical

Back to top